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ABSTRACT  
Aims: Performance in cancer Multidisciplinary Team Meetings (MDMs) can compromise treatment 
decision-making, yet improvement tools that can be used by peers in routine practice are lacking. 
Our aims were to develop a tool for independent observational assessment, and test criterion 
validity (Study 1); followed by inter-rater reliability and agreement when used by clinicians vs. non-
clinicians, and describe performance in 10 cancer MDMs (Study 2). 
Design: The MDT- Meeting Observational Tool (MOT) was developed. Ten teamwork domains are 
rated on a 5-point Likert scale using descriptive anchors. Study 1: 13 health service staff observed 
and rated pre-determined optimal/sub-optimal MDM film excerpts. Study 2: video-recordings of 10 
MDMs were independently rated by clinical and non-clinical observers.  Inter-rater reliability and 
agreement was assessed and variability between MDTs described using non-parametric statistics.   
Results: Study 1: Observers were able to discriminate between optimal and sub-optimal MDM 
performance (p≤0.05). Study 2: Inter-rater reliability was good for 3/10 domains. Percentage of 
absolute agreement was high (≥80%) for 4/10 domains and percentage agreement within 1 point 
was high for 9/10 domains. Four MDTs performed well (scored 3+ in at least 8/10 domains), five 
MDTs performed well in 6-7 domains, and one MDT performed well in only 4 domains. Leadership 
and chairing of the meeting, the organisation and administration of the meeting, and clinical 
decision-making processes all varied significantly between MDMs (p≤0.01).  
Conclusions: MDT-MOT demonstrated good criterion validity. Agreement between clinical and non-
clinical observers (within one point on the scale) was high but this was inconsistent with reliability 
coefficients and warrants further investigation. If further validated MDT-MOT might provide a useful 
mechanism for the routine assessment of MDMs by the local workforce to drive improvements in 
MDT performance. 
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INTRODUCTION 
Tumour specific multi-disciplinary teams (MDTs, sometimes called multi-disciplinary tumour boards) 
are now firmly established as fundamental to the organisation of cancer services in the UK and other 
countries [1-3]. A central component of the MDT model of care is the regular MDM, bringing together 
a range of health professionals to agree recommendations about the management of patients. With 
accumulating evidence of the benefits that cancer MDTs confer [3], including reduced variation in 
survival [4-6], there has been increasing emphasis on ensuring that MDTs perform both effectively 
and efficiently in order to deliver optimal patient care [7-8]. 
In England some aspects of MDT working, such as MDT membership and whether protocols for referral 
and treatment are in place, are assessed through the national cancer peer review programme. [9] 
Adherence to these standards, within and between tumour types, is variable [10] and many other 
aspects of teamworking are not easily translated to measurable national standards, but may equally 
impact on the quality of care. This includes the quality of leadership of the MDT, the patient-
centredness of the decision-making process and the inclusiveness and quality of communication 
between MDT members [11-13]. Poor quality discussions in MDMs, particularly the failure to consider 
all relevent information, may result in recommendations that are not implemented in practice[14-16] 
and/or cause delays in patient treatment [17-18].  
Structured observational assessment and feedback has proved a useful technique to help drive 
improvements in the way health teams work together, for example during surgical procedures [19]; 
and in anaesthesia [20]. Independent observers can potentially help MDT members to recognise areas 
where performance could be improved that they may not have been aware of themselves including 
what they are doing well as well as what could be improved [21]. Structured observational assessment 
tools for assessing MDT performance within cancer MDMs have been developed [22-23] but cannot 
be easily used without some training and supervision. Furthermore, although the assessment of 
teamwork in routine practice may be beneficial and cost-effective for encouraging health professional 
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development [24], formalised mechanisms to facilitate this are lacking (eg using standardized 
processes, assessing measurable quality standards)[7]. For the routine observational assessment of 
cancer MDMs to be sustainable and encourage organisational learning, it would need to be feasible 
for assessments to be undertaken by locally based health services staff, rather than costly external 
teamwork experts or specialist researchers [25]. We have previously established proof of concept that 
it is feasible for health service clinicians and managers with no formal training in observational 
techniques to undertake structured observational assessment and that MDT members find such 
feedback useful [26].  
The Characteristics of an Effective MDT [7], produced by England’s National Cancer Action Team 
(NCAT), outlines the optimal components of MDT performance based on clinical consensus from a 
survey completed by over 2,000 cancer MDT members. It contains nearly 100 recommendations for 
effective cancer teamworking organised under 17 ‘domains’, many of which are potentially observable 
in MDMs. We have previously used this as a framework to underpin the development of a 
questionnaire, the Team Evaluation and Assessment Measure [27], to enable MDT members to self-
assess their performance. In this study we aimed to develop an observational assessment tool, 
underpinned by the Characteristics of an Effective MDT, suitable for routine use in cancer MDMs by 
clinical and non-clinical professionals (including health service staff with no previous experience of 
conducting such assessments). The objectives were: 
a) To test criterion validity, the extent to which it can discriminate between different levels of 
performance, when used by health service staff without prior training (Study 1) 
b) To test reliability and agreement when used by different observers, including clinical and 
non-clinical assessors (Study 2) 
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c) To describe team performance in cancer MDMs (including variation within and between 
MDTs, as well as describing the aspects of teamwork performed most and least well) (Study 
2). 
METHODS 
Tool development 
Preliminary work was undertaken with 20 MDTs and has been described in detail elsewhere [26]. The 
content was calibrated against the Characteristics of an Effective MDT [7]. Of the 17 domains of 
teamwork within this document, the tool includes 10 that are observable in MDMs. Domains include: 
attendance at MDT meetings, leadership and chairing in MDT meetings, teamworking and culture, 
personal development and training, physical environment of the meeting venue, technology and 
equipment available for use in MDT meetings, organisation and administration during meetings, 
patient-centred care, clinical decision-making processes, and post-meeting co-ordination of service 
(e.g. the clarity of ‘next steps’ in the meeting discussion). A prototype version was tested for proof of 
concept with 20 MDTs [26]. Key findings were that the tool was acceptable and useful but usability 
could be improved by incorporating descriptive textual ‘anchors’ for extreme and mid points on the 
scale.  
The tool was modified to improve format and usability. This included developing descriptive anchors 
for scores at the lower, mid and upper end of the rating scale. The revised tool was subsequently 
piloted by: (1) a senior cancer nurse and a surgeon (RJ) who observed video-recordings of five MDMs; 
(2) six NHS Trust-based peer observers (senior clinicians and managers) observing MDTs within their 
Trust in-vivo; and (3) an independent multidisciplinary panel of cancer service researchers. All users 
provided feedback on face and content validity, acceptability and ease of use, and further changes 
were made including refinements to the descriptive anchors and format/layout of the tool. 
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In the resulting MDT-Meeting Observational Tool (hereafter referred at as MDT-MOT) all 10 
observable teamwork domains are rated on a 5-point rating scale, using descriptive anchors for the 
extremes and midpoint of the scale [28]. A score of ‘5’ represents optimal effectiveness, calibrated 
against recommendations within ‘The Characteristics of an Effective MDT’ [7]. A score of ‘3’ represents 
effectiveness that exhibits some degree of agreement with the optimum, but not consistently, and a 
score of ‘1’ represents no or little agreement with the defined optimum. Scores of ‘2’ and ‘4’ were 
included but not defined to allow observers the freedom to gradate their assessment. This approach 
to observational scoring (high, medium and low anchors, plus intermediate scores that allow 
gradation) is particularly useful for assessing workplace performance [28] and has used been 
extensively in relation to assessing team performance [19, 22-23] (See Figure 1). 
Study 1: assessing criterion validity when used by health service staff without prior training  
Participants  
Observers were 13 participants at a workshop (facilitated by CT and JH) about MDT working within a 
national cancer conference in England. Participants included one clinician and twelve non-clinicians 
(e.g. cancer service managers). None had undertaken structured observational assessment previously.  
Procedure 
Participants were given a brief introduction to the purpose and use of MDT-MOT and were then asked 
to use MDT-MOT to independently rate the performance of MDTs they viewed on 2 brief films. The 
films consisted of re-enacted MDM excerpts (real meetings were filmed and re-produced faithfully by 
actors). The films were developed by the National Cancer Action Team (NCAT, responsible for 
supporting implementation of cancer policy in England at the time) overseen by a panel of cancer 
experts to illustrate the characteristics of an effective MDT. The excerpts included MDT discussions 
where optimal and sub-optimal behaviour are shown (film 2 and 1, respectively) lasting approximately 
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12 minutes in total. Participants were asked to act as the independent observer for the MDT and to 
use MDT-MOT to rate each MDT film individually.  
Study 2: assessing MDT performance, inter-rater reliability and agreement using clinical and non-
clinical observers 
MDT meetings 
10 cancer MDMs were video-recorded; this included two colorectal, two upper GI, two head and neck, 
two skin, one teenage and young adult, and one urology MDT.  
Procedure 
MDMs were video-recorded using a digital camcorder with a wide angled lens and external 
microphone, set on a tripod (facing the attendees). MDT members were asked to maintain patient 
anonymity in discussions by referring to patients using ID numbers instead of their names. 
Subsequently, a surgeon registrar (RJ) and research psychologist (JH) independently viewed the films 
and assessed each MDM using the MDT-MOT. Both were experienced at assessing MDT performance 
and using observational tools, one was experienced at using the MDT-MOT (JH).  
Data analyses 
In Study 1 criterion validity was established if observers’ were able to discriminate between optimal 
(film 2) and sub-optimal performance (film 1), assessed using Mann-Whitney U tests. In Study 2 
descriptive statistics (mean, SD, median, range) for the performance scores per domain are presented. 
Inter-rater reliability, the extent to which the observers were able to differentiate between MDT 
performance in each domain of teamworking, was assessed statistically using weighted Kappa.[29] 
Inter-rater agreement, the extent to which the ratings were identical, was assessed by presenting 
percentage agreement (both absolute agreement, and within 1-point on the scale).[30] Variation in 
performance between MDTs was assessed statistically using Kruskal Wallis. To enable visual 
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comparison of variation between and within MDTs, the summed overall score out of 50 was calculated 
and ratings for each domain were dichotomised with scores above 3 indicating ‘best performance’ vs. 
scores of 3 or less. All statistical tests were performed using SPSS version 20.0. Significance was taken 
at the 0.05 level. The methods presented here align closely with those described in published 
reporting guidelines for reliability and agreement (see the appendices).[30] 
Ethics  
The protocol for the project was reviewed by the UK National Research Ethics Service (NRES) and was 
classified and approved as service development.  
RESULTS 
Study 1: Criterion validity of MDT-MOT  
Median and mean observer ratings for film 1 (worse teamworking) were 2.5 or less, for nine out of 
ten domains, indicating agreement from the raters that the team exhibited sub-optimal performance. 
The exception was the physical environment of the meeting venue, with a median rating of 3. In 
comparison, median and mean observer ratings for film 2 (better teamworking) were all greater than 
3, indicating agreement between raters that the team exhibited better performance than film 1 (table 
1). Within-observer comparison of ratings for the two films revealed significant differences for all 
domains of MDM performance (all p ≤ 0.05; data not shown, available on request), suggesting that 
MDT-MOT could reliably discriminate between better and worse MDT performance.  
Table 1 here 
 
 
 
Study 2: Characteristics of cancer MDT meetings   
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Between 4 and 33 cases were discussed at each meeting (median = 14 cases, mean = 38.6 cases, SD = 
1.4) with an average of 10 MDT-members in attendance (range 8 to 12) (table 2).  
[Table 2] 
Inter-rater reliability and agreement using MDT-MOT 
Weighted Kappa (K) statistics indicated good reliability for three domains of teamworking: clinical 
decision-making, organisation and administration during MDT meetings, and leadership of the team 
and chairing of the MDT meeting (K ≥0.60).[29,31] Percentage agreement showed that in these three 
domains, plus one further (patient-centred care)at least 80% of observers’ ratings were in absolute 
agreement; and in all but one domain (attendance at MDMs)at least 80% of the ratings agreed at least 
within 1-point on the scale (table 3).  
[Table 3] 
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Variation in performance within and between MDTs   
There was evidence of consistency in performance across domains within teams, with four MDTs 
performing well (‘good’ or ‘very good’ i.e. score greater than 3) in 8 or 9 domains, five MDTs 
performing well in 6 or 7 domains, and one MDT performing well in only 4 domains (table 4, figure 2).  
There was diversity in performance between MDTs. Total scores (out of 50) ranged from 32 to 40 
(table 4). Ratings of performance in relation to leadership and chairing of the meeting, organisation 
and administration during meetings, and clinical decision-making processes all varied significantly 
between MDTs (Kruskal-Wallis test, ≤ 0.05; data not shown, available on request). No other significant 
variations in domains between MDTs were found. All MDTs were evaluated well for the physical 
environment of the meeting venue, but only one MDT performed well in demonstrating evidence of 
personal development and training within their MDM.  
[Table 4] 
DISCUSSION 
This study offers preliminary evidence that the MDT-MOT has good criterion validity. However the 
results for reliability and agreement were inconclusive. The findings suggest that, when used by a 
clinical and non-clinical assessor, MDT-MOT could reliably differentiate performance for three of the 
ten domains of cancer teamworking, but ratings given for 9 out of the 10 domains of teamworking by 
the two raters were at least within 1 point of each other 80% of the time, showing high agreement. 
This is important because it suggests there was some consistency between observers’ ratings. The 
discrepancy between the reliability and agreement coefficients is an acknowledged statistical paradox 
and is challenging to interpret, particularly because Kappa coefficients are influenced by the 
prevalence of the phenomenon being measured and sample size [29, 32, 33]. In this study MDTs 
tended to perform well, with a high prevalence of positive ratings; in such instances chance agreement 
would be high and Kappa is reduced accordingly. Furthermore, the sample size of 10 MDTs, although 
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comparing favourably to samples in the development of similar tools [22, 23], may not be sufficient 
to detect a statistically significant coefficient [33]. This is because the MDT-MOT assesses overall 
meeting performance rather than performance on a patient-by-patient basis (e.g. MDT- Metric for the 
Observation of Decision-making(MODe)) [22]. Therefore we suggest that the percentage agreement 
provides a more useful indicator of reliability in this instance.   
 
As this is the first evaluation of MDT-MOT is unclear to what extent any discrepancies between 
observers are an artefact of the tool, or may reflect the clinical/non-clinical backgrounds of the 
observers, and/or their professional biases or experiences as a surgeon and psychologist. The 
differences may alternatively be accounted for by having varied observer learning curves for using the 
tool, as one observer was more experienced at using MDT-MOT, as found with other measures [22, 
34]. Furthermore, it is likely that some training or at least preparation (e.g. practice using the tool) 
would optimise the reliability of assessments [25]. Future research should test the reliability of MDT-
MOT in the hands of clinical and non-clinical ‘peer’ observers attending meetings in person, an 
approach that has been used in the development of other tools [22]. In addition, it would be valuable 
to evaluate the utility and validity of MDT-MOT in relation to existing team member self-assessment 
tools [27] and other MDT observational measures [22, 23], and to obtain MDT members’ views of its 
utility for MDT development. Furthermore, it would be useful to examine the tools’ performance 
when used with MDTs that may operate differently (e.g. ‘speciality’ MDTs such a paediatric and rarer 
tumours), and in contexts outside the UK.   
MDT-MOT is intended to support team development. Our findings are unlikely to impact on the overall 
utility of the scale when used in routine practice for this purpose, as it is intended to be used as part 
of a toolkit to enable MDT members to assess and receive feedback on their MDT performance (e.g. 
to be used alongside MDT member self-assessment and review of practice, audit of clinical practice, 
and patient experience survey data), all of which may capture different aspects of performance [21]. 
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Indeed previous research has shown that not only do cancer MDT members assess their MDTs 
performance differently to external observers particularly in relation to the degree of patient-
centredness demonstrated in meetings [21], but there may also be considerable variability in how 
members of the same MDT view the purpose of the MDT in relation to this domain [35].   
Although most MDTs performed well, performance did vary between MDTs. In contrast to findings in 
a previous study within one tumour type (colorectal) [23] the MDTs in this study typically performed 
well in relation to having patient-centred discussions, documenting post-meeting actions, and having 
suitable meeting venues. MDTs appeared not to prioritise integration of explicit training into MDMs. 
This putative benefit of MDMs is cited by MDT members’ themselves [7]; however, it may be that in 
time-pressured meetings it is neglected.  
The quality of leadership including chairing of the MDMs also varied considerably. Within the UK 
context, clinicians typically hold leadership roles due to their clinical expertise, but little opportunity 
or support is provided for leadership development [36; 37]. Incorporating the assessment of MDMs 
into routine practice could have benefits for individuals, teams and the wider organisation by sharing 
best practice and highlighting areas for improvement that could be prioritised for investment/training.  
Some limitations should be noted. In order to assess criterion validity when used by non-experts 
without prior training, study 1 utilised films of re-enacted meetings that had been intentionally 
produced to represent optimal and sub-optimal team performance as has been used in the 
development of other tools [38]. However, as these were excerpts they were much shorter than a 
usual MDM: whole MDMs are likely to contain greater gradations with regards to performance. Study 
1 participants were a convenience sample and only included one clinician; future research would 
benefit from testing with a wider variety of clinical and non-clinical staff, and across a range of MDM 
settings.  The MDTs in study 2 were also a small convenience sample and thereby caution must be 
exercised when generalising beyond these teams, for instance perhaps MDTs that performed better 
were more likely to consent to being observed. However, the sample did include a range of tumour 
Cancer Multidisciplinary Team Meeting Observational Tool (MDT-MOT) 
 
14 
 
specialties from six NHS Trusts, and the overall number of cases discussed is comparable to those 
reported in the development of other observational tools [22-23]. The MDMs we recorded were 
stated to be “typical” of the weekly MDM by the team members, though it is recognised that in the 
busy environment of a case discussion meeting it may be difficult to assess all aspects of the discussion 
[22, 39]. However, MDT-MOT was designed for the routine assessment of usual busy cancer MDMs 
by local health services staff with minimum training, and it is reassuring that in this context we have 
been able to demonstrate criterion validity and good agreement between raters, although the 
reliability statistics present a weaker agreement and warrant further investigation.  
CONCLUSIONS 
If further validated, MDT-MOT may provide a useful mechanism for the routine assessment of MDM 
effectiveness. This could not only assist individual MDTs in recognising where they perform well and 
those areas to prioritise for development and improvement, but also benefit the wider healthcare 
organisation. Sharing best practice may help organisations to identify where they could support their 
MDTs further to promote the delivery of effective MDMs and patient care.    
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Tables 
Table 1. Study 1: Ratings for domains of MDT meeting performance in each film   
Sub-domains of MDT 
meeting performance 
assessed 
Film 1 (worse teamwork) Film 2 (better teamwork) Statistical 
significance+  Median 
Min-Max Mean SD 
Median 
Min-Max Mean SD 
Attendance at MDT 
meetings 
1.0 1-3 1.73 0.91 4.0 3-5 3.91 0.83  U(20)= 6.0,  
Z= -3.70, p <0.001 
Leadership and chairing  1.0 1.00 1.00 0.00 5.0 4-5 4.69 0.48 U(24) = 0.0,  
Z= -4.75, p <0.001 
Teamwork and culture 1.0 1-2  1.15 0.38 5.0 4-5 4.75 0.45 U(23)= 0.0,  
Z= -4.56, p <0.001 
Personal development and 
training 
1.0 1-2 1.25 0.46 3.0 1-5 3.14 1.68  U(13)= 10.0,  
Z= -2.27, p =0.023 
Physical environment of the 
meeting venue 
3.0 1-4 2.46 1.05 3.5 2-5 3.67 0.99 U(23)= 34.0,  
Z= -2.50, p= 0.013 
Technology and equipment 
available for use in MDT 
meetings 
2.5 1-5 2.42 1.31 5.0 2-5 4.54 0.97 U(23)= 17.5,  
Z= -3.47, p= 0.001 
Organisation and 
administration during MDT 
meetings 
1.0 1-2 1.23 0.44 4.0 3-5 4.38 0.65  U(24)= 0.0,  
Z= -4.52, p= 0.001 
Patient-centred care 1.0 1-2 1.33 0.49 5.0 4-5 4.85 0.38 U(23)= 13.0,  
Z= -.3.75, p< 0.001 
Clinical decision-making 1.0 1-3 1.38 0.65 5.0 3-5 4.69 0.63  U(24)= 0.5,  
Z= -4.54, p< 0.001 
Post- meeting coordination 
of services 
1.0 1-3 1.44 0.73 4.0 2-5 3.86 1.22 U(14)= 3.0,  
Z= -3.13, p= 0.002 
+ Significance of difference between ratings for film 1 and 2, Mann-Whitney U test 
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Table 2. Study 2: Characteristics of the observed MDT meetings 
MDT meeting 
observed 
Number of patient 
cases discussed in 
meeting  
Meeting duration 
(minutes) 
Number of MDT 
members in 
attendance at the 
meeting  
Colorectal   21 99 11 
Colorectal   13 64 9 
Colorectal 16 97 11 
Head and neck 9 43 11 
Head and neck 17 78 10 
Skin 14 54 9 
Teenage and 
young adult 
10 32 8 
Upper GI 14 80 9 
Upper GI 4 30 12 
Urology  33 118 8 
Total  151 695 98 
Mean  15 126 10 
Median 14 71 10 
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Table 3. Study 2: Observers’ ratings for domains of MDT meeting performance: reliability and agreement   
Domain of MDT meeting 
Observer 1 (surgeon) Observer 2 (psychologist) Reliability1 Percentage agreement 
Median Min-
Max 
Mean SD Median Min-
Max 
Mean SD Weighted 
Kappa 
Absolute 
agreement  
Agreement  
-/+ 1 point  
Attendance at MDT 
meetings 
3.5 2-5 3.8 1.14 4 3-5 4.1 0.88 0.17 40 70 
Leadership and chairing  4.0 1-5 3.6 1.17 4 2-4 3.4 0.84 0.62 90 100 
Teamwork and culture 4.0 3-4 3.9 0.32 4 3-5 3.8 0.63 0.32 70 100 
Personal development 
and training 
2.0 2-3 2.40 0.52 3 2-4 2.8 0.63 0.06 50 100 
Physical environment of 
the meeting venue 
4.0 3-5 4.2 0.63 4 4-5 4.1 0.63 0.32 70 100 
Technology and 
equipment available for 
use in MDT meetings 
4.0 3-4 3.8 0.50 4 3-5 3.7 0.68 0.45 50 80 
Organisation and 
administration during 
MDT meetings 
4.0 3-5 3.7 0.68 4 3-4 3.6 0.52 0.83 90 100 
Patient-centred care 4.5 3-5 3.9 0.74 4 3-5 3.7 0.68 0.24 80 100 
Clinical decision-making 4.0 3-5 3.7 0.68 4 3-4 3.6 0.52 0.83 90 100 
Post- meeting 
coordination of services 
4.5 3-5 4.4 0.70 4 3-5 4.1 0.88 -0.07 20 90 
1 Weighted Kappa interpretation: ≤0 poor, .01-.20 = slight, .21-.40= fair, .41-.60= moderate, 0.61-.80 = substantial and .81-1= almost perfect (Landis and 
Koch, 1977) 
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Table 4. Study 2: Variation in performance across the ten observable domains of teamworking within and between teams 
Domain of MDT meeting 
performance  
MDT  Number of 
MDTs 
scoring >3  
1 2 3 4 5 6 7 8 9 10 
Mean score (1-5)1 
Attendance at MDT 
meetings 
4 4 5 5 3 4 4 5 3 4 8 
Leadership and chairing  3 4 4 4 5 3 4 2 3 5 6 
Teamwork and culture 4 4 4 4 4 4 4 4 3 5 9 
Personal development and 
training 
3 3 3 2 3 3 3 3 2 4 1 
Physical environment of the 
meeting venue 
5 4 4 4 5 4 4 5 4 4 10 
Technology and equipment 
available for use in MDT 
meetings 
4 4 3 4 5 4 3 4 4 3 7 
Organisation and 
administration during MDT 
meetings 
3 4 4 5 4 4 3 4 3 3 6 
Patient-centred care 4 4 4 5 5 3 4 5 4 4 9 
Clinical decision-making 3 4 5 4 3 4 4 4 3 3 6 
Post- meeting coordination 
of services 
5 5 4 5 5 4 4 5 4 5 10 
Total score  
(potential range 10-50) 
Number of domains > 3 
37 
 
6 
39 
 
9 
38 
 
8 
40 
 
9 
39 
 
7 
36 
 
7 
36 
 
7 
39 
 
9 
32 
 
4 
38 
 
7  
1 Based on the two observers' combined ratings 
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Legends for figures: 
Figure 1 MDT-MOT© Rating scale for three domains of teamworking (for illustration) 
Figure 2. Variation in MDT performance by domain of teamworking 
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Figures 
 
Figure 1 MDT-MOT© Rating scale for three domains of teamworking (for illustration) 
 
Aspect of teamworking Description of team performance (5 = very good; 1 = very poor) 
5 4 3 2 1 
ATTENDANCE 
 All core and extended members attend for 
all cases relevant to them 
 Decisions are only made when meeting is 
quorate 
 Observers/new team-members are 
introduced 
 
 At least one core member is absent 
for some cases relevant to them (e.g. 
arrives late/leaves early) 
 Some decisions are made when the 
meeting is not quorate; 
 Observers/new team-members are 
introduced inappropriately (before 
meeting is quorate; not all observers 
are introduced) 
 
 At least one core and extended 
team member are absent for all 
cases relevant to them; 
 Many decisions are made when 
the meeting is not quorate; 
 Observers/ new team-members 
are not introduced 
LEADERSHIP/CHAIRING OF THE 
MDT MEETING 
The Chair; 
 manages people, discussions and time 
effectively 
 monitors attendance and takes action on 
attendance concerns as appropriate 
 ensures recommendations are 
clear/consensual in all cases 
 
The Chair; 
 manages people, discussions and/or 
time reasonably well (e.g. loses 
control of some case 
discussions/time but most are OK) 
 acknowledges attendance issues but 
does not take the appropriate 
action 
 does not ensure recommendations 
are clear and/or consensual in some 
cases 
 
The Chair; 
 manages people, discussions 
and/or time poorly 
 does not acknowledge or act on 
attendance issues (e.g. does not 
announce if key team members are 
absent and/or defer decisions if 
meeting is not quorate) 
 fails to ensure recommendations 
are clear and/or consensual in 
many cases 
TEAMWORKING AND CULTURE 
The team always displays acceptable team 
behaviour including: 
 respect, 
 equality/ inclusiveness of discussion 
 no inter-personal conflict evident/or 
effective conflict management takes place 
 
 The team displays a few minor 
instances of unacceptable team 
behaviour 
 The behaviour is not sustained and 
do not appear to impact on the 
whole meeting 
 
 The team displays clear/repeated 
instances of unacceptable team 
behaviour 
 The behaviour is sustained and/or 
appears to impact on the whole 
meeting. 
© Green Cross Medical Ltd
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Figure 2. Variation in MDT performance by domain of teamworking 
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